Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clio P Mavragani

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Journal of Autoimmunity|July 13, 2013
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndromeAdrianos Nezos, Aristea Papageorgiou, George Fragoulis, et al.
Clinical Immunology (Orlando, Fla.)|December 16, 2020
Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunityClio P Mavragani, Kyriakos A Kirou, Adrianos Nezos, et al.
Journal of Clinical Medicine|February 11, 2021
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's SyndromeEvangelia Argyriou, Adrianos Nezos, Petros Roussos, et al.
Rheumatology (Oxford, England)|June 8, 2010
Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptidesDimitrios Karaiskos, Clio P Mavragani, Maria Hamze Sinno, et al.
Clinical Immunology (Orlando, Fla.)|June 5, 2021
Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus ErythematosusPanagiotis A Ntouros, Nikolaos I Vlachogiannis, Maria Pappa, et al.
Frontiers in Immunology|August 23, 2013
Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associationsClio P Mavragani, Timothy B Niewold, Antonis Chatzigeorgiou, et al.
Cytokine|July 22, 2022
Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individualsClio P Mavragani, Charalampos Skarlis, Ioannis V Kostopoulos, et al.
Journal of Autoimmunity|May 20, 2016
Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritisSophia Lionaki, Clio P Mavragani, Alexandre Karras, et al.
Journal of Autoimmunity|July 26, 2021
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature reviewAthanasios-Dimitrios Bakasis, Clio P Mavragani, Kyriaki A Boki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferationAristea Papageorgiou, Clio P Mavragani, Andrianos Nezos, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Journal of Autoimmunity|July 13, 2013
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndromeAdrianos Nezos, Aristea Papageorgiou, George Fragoulis, et al.
Clinical Immunology (Orlando, Fla.)|December 16, 2020
Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunityClio P Mavragani, Kyriakos A Kirou, Adrianos Nezos, et al.
Journal of Clinical Medicine|February 11, 2021
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's SyndromeEvangelia Argyriou, Adrianos Nezos, Petros Roussos, et al.
Rheumatology (Oxford, England)|June 8, 2010
Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptidesDimitrios Karaiskos, Clio P Mavragani, Maria Hamze Sinno, et al.
Clinical Immunology (Orlando, Fla.)|June 5, 2021
Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus ErythematosusPanagiotis A Ntouros, Nikolaos I Vlachogiannis, Maria Pappa, et al.
Frontiers in Immunology|August 23, 2013
Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associationsClio P Mavragani, Timothy B Niewold, Antonis Chatzigeorgiou, et al.
Cytokine|July 22, 2022
Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individualsClio P Mavragani, Charalampos Skarlis, Ioannis V Kostopoulos, et al.
Journal of Autoimmunity|May 20, 2016
Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritisSophia Lionaki, Clio P Mavragani, Alexandre Karras, et al.
Journal of Autoimmunity|July 26, 2021
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature reviewAthanasios-Dimitrios Bakasis, Clio P Mavragani, Kyriaki A Boki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferationAristea Papageorgiou, Clio P Mavragani, Andrianos Nezos, et al.
Pageof 12